Shyamal Yashvantray Bhalani
About Shyamal Yashvantray Bhalani
Data last updated:
Shyamal Yashvantray Bhalani is a Director at Pramukh Swami Pharma Limited (since 2008) and Director at Patson Laboratories Private Limited (since 2015). The companies operate in Pharma. The 2 current companies with reported revenue have a combined latest revenue of ₹10.23 Cr; the largest is Pramukh Swami Pharma Limited at ₹7.07 Cr (FY 2025). Earlier, Shyamal Yashvantray Bhalani was a Director at Naxcuure Healthcare Private Limited (2017–2025) and Director at Supal Pharmacare Limited (2023–2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Pramukh Swami Pharma Limited U24231GJ1997PLC032344 | Director | 12 Mar 2008 | 1997 | ₹7.07 Cr (FY 2025) | Active |
| Patson Laboratories Private Limited U24231GJ1993PTC019197 | Director | 01 Jun 2015 | 1993 | ₹3.17 Cr (FY 2025) | Active |
Previous companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
| Naxcuure Healthcare Private Limited U74999GJ2017PTC100178 | Director | 18 Dec 2017 | 2017 | ₹17.88 Cr (FY 2025) | Active |
| Supal Pharmacare Limited U47721GJ2023PLC142969 | Director | 22 Nov 2023 | 2023 | ₹33.91 Cr (FY 2024) | Active |
Explore Director's current and past company associations Uncover their professional journey today!
Board colleagues of Shyamal Yashvantray Bhalani
| Name | DIN | Company | Designation |
|---|---|---|---|
| Dineshkumar Navadiya | 01076357 | Pramukh Swami Pharma Limited | Director |
| Vasantiben Yashvantray Bhalani | 01861499 | Pramukh Swami Pharma Limited | Director |
| Yashvantray Odhavji Bhalani | 01861497 | Pramukh Swami Pharma Limited | Managing Director |
| Anandkumar Shashikant Parekh | 08370107 | Patson Laboratories Private Limited | Director |
| Jolly Anandkumar Parekh | 08641757 | Patson Laboratories Private Limited | Director |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Shyamal Yashvantray Bhalani
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Shyamal Yashvantray Bhalani
Shyamal Yashvantray Bhalani currently holds 2 directorships: Pramukh Swami Pharma Limited (Director, since 12 Mar 2008, revenue ₹7.07 Cr (FY 2025)); Patson Laboratories Private Limited (Director, since 01 Jun 2015, revenue ₹3.17 Cr (FY 2025)).
Shyamal Yashvantray Bhalani was first appointed on 12 Mar 2008 as Director at Pramukh Swami Pharma Limited. The most recent appointment on record is 22 Nov 2023 at Supal Pharmacare Limited.
The 2 current companies of Shyamal Yashvantray Bhalani that report revenue have a combined latest revenue of ₹10.23 Cr: Pramukh Swami Pharma Limited ₹7.07 Cr (FY 2025); Patson Laboratories Private Limited ₹3.17 Cr (FY 2025).
Shyamal Yashvantray Bhalani held 2 earlier board appointments: Naxcuure Healthcare Private Limited (Director, 18 Dec 2017 to 22 Dec 2025); Supal Pharmacare Limited (Director, 22 Nov 2023 to 01 Apr 2024).
The current boards of Shyamal Yashvantray Bhalani's companies include Dineshkumar Navadiya (Pramukh Swami Pharma Limited), Vasantiben Yashvantray Bhalani (Pramukh Swami Pharma Limited), Yashvantray Odhavji Bhalani (Pramukh Swami Pharma Limited), Anandkumar Shashikant Parekh (Patson Laboratories Private Limited), Jolly Anandkumar Parekh (Patson Laboratories Private Limited).